BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38379052)

  • 1. Disseminated nocardiosis and anti-GM-CSF antibodies.
    Brugnoli B; Salvati L; Di Lauria N; Botta A; Tozzetti C; Biscarini A; Capone M; Ferrentino F; Naldi C; Ascione G; Mazzoni A; Maggi L; Campo I; Carey B; Trapnell B; Liotta F; Cosmi L; Bartoloni A; Annunziato F; Parronchi P; Palterer B
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):1003-1007. PubMed ID: 38379052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
    Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
    Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis.
    Salvator H; Cheng A; Rosen LB; Williamson PR; Bennett JE; Kashyap A; Ding L; Kwon-Chung KJ; Namkoong H; Zerbe CS; Holland SM
    Respir Res; 2022 Oct; 23(1):280. PubMed ID: 36221098
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kerdiles T; Lejeune S; Portais A; Bourgeois G; Lefevre B; Charmillon A; Sixt T; Moretto F; Cornille C; Vidal M; Coustillères F; Martellosio JP; Quenet M; Belan M; Andry F; Jaffal K; Pinazo-Melia A; Rondeau P; Luque Paz D; Jouneau S; Borie R; Monnier D; Lebeaux D;
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae269. PubMed ID: 38915339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.
    Ataya A; Knight V; Carey BC; Lee E; Tarling EJ; Wang T
    Front Immunol; 2021; 12():752856. PubMed ID: 34880857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association.
    Viola GM; Malek AE; Rosen LB; DiNardo AR; Nishiguchi T; Okhuysen PC; Holland SM; Kontoyiannis DP
    Mycoses; 2021 Jun; 64(6):576-582. PubMed ID: 33476401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Case of
    Makadia S; Patel I; Soosaipillai I; Tarasiuk-Rusek A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620938228. PubMed ID: 32602372
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutralizing Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Patients With Central Nervous System and Localized Cryptococcosis: Longitudinal Follow-up and Literature Review.
    Kuo PH; Wu UI; Pan YH; Wang JT; Wang YC; Sun HY; Sheng WH; Chen YC; Chang SC
    Clin Infect Dis; 2022 Aug; 75(2):278-287. PubMed ID: 34718451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte Macrophage Colony-Stimulating Factor-Specific Autoantibodies and Cerebral Nocardia With Pulmonary Alveolar Proteinosis.
    Berthoux C; Mailhe M; Vély F; Gauthier C; Mège JL; Lagier JC; Melenotte C
    Open Forum Infect Dis; 2021 Feb; 8(2):ofaa612. PubMed ID: 33614812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis.
    Arango-Franco CA; Migaud M; Ramírez-Sánchez IC; Arango-Bustamante K; Moncada-Vélez M; Rojas J; Gervais A; Patiño-Giraldo S; Perez-Zapata LJ; Álvarez Álvarez JA; Orrego JC; Roncancio-Villamil G; Boisson-Dupuis S; Jouanguy E; Abel L; Casanova JL; Bustamante J; Arias AA; Franco JL; Puel A
    J Clin Immunol; 2023 Jul; 43(5):921-932. PubMed ID: 36821021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.
    Rosen LB; Freeman AF; Yang LM; Jutivorakool K; Olivier KN; Angkasekwinai N; Suputtamongkol Y; Bennett JE; Pyrgos V; Williamson PR; Ding L; Holland SM; Browne SK
    J Immunol; 2013 Apr; 190(8):3959-66. PubMed ID: 23509356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
    Latzin P; Tredano M; Wüst Y; de Blic J; Nicolai T; Bewig B; Stanzel F; Köhler D; Bahuau M; Griese M
    Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Carey B; Chalk C; Suzuki T; Sakagami T; Koch DE; Stevens C; Inoue Y; Yamada Y; Trapnell BC
    J Immunol Methods; 2014 Jan; 402(1-2):57-70. PubMed ID: 24275678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
    Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
    Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.